 |
Articles: Inflammatory Bowel Dz |
Influence of NFkB inhibitors on IL-1beta-induced chemokine CXCL8 and -10 expression levels in intestinal epithelial cell lines: glucocorticoid ineffectiveness and paradoxical effect of PDTC
International Journal of Colorectal Disease, 11/24/09
Anti-TNF-Alpha-Induced Psoriasis - An Unusual Paradox
Case Reports in Gastroenterology, 11/24/09
Prior Articles
The path to Crohns disease: Is mucosal pathology a secondary event
Inflammatory Bowel Disease, 11/23/09 Methotrexate for maintenance of remission in chronic active Crohns disease: Long-term single-center experience and meta-analysis of observational studies
Inflammatory Bowel Disease, 11/23/09 Do Non-steroidal Anti-inflammatory Drugs Cause Exacerbations of Inflammatory Bowel Disease
Digestive Diseases and Sciences, 11/23/09 Magnetic resonance follow-through imaging for evaluation of disease activity in ileal Crohns disease: An observational, retrospective cohort study
Inflammatory Bowel Disease, 11/23/09 Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohns disease
Inflammatory Bowel Disease, 11/23/09 Ulcerative colitis in northern Portugal and Galicia in Spain
Inflammatory Bowel Disease, 11/23/09 Disease-Related Expression of the IL-6 / STAT3 / SOCS3 Signaling Pathway in Ulcerative Colitis and Ulcerative Colitis-Related Carcinogenesis
Gut, 11/23/09 Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
New England Journal of Medicine, 11/20/09 Certolizumab pegol for the treatment of Crohn's disease
Expert Review of Clinical Immunology, 11/19/09 Impact of disease activity on resting energy expenditure in children with inflammatory bowel disease
Clinical Nutrition, 11/18/09 Validation of the Spanish version of a questionnaire to measure quality of care through the eyes of patients with inflammatory bowel disease (QUOTE-IBD)
Inflammatory Bowel Disease, 11/18/09 Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease
Inflammatory Bowel Disease, 11/18/09 Postoperative Management of Crohn Disease
Gastroenterology Clinics of North America, 11/17/09 Safety Profile of IBD Therapeutics: Infectious Risks
Gastroenterology Clinics of North America, 11/17/09 Clostridium Difficile and Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/17/09 Novel Diagnostic and Prognostic Modalities in Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/17/09 Safety Profile of IBD: Lymphoma Risks
Gastroenterology Clinics of North America, 11/16/09 Pregnancy and Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/16/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Gastroenterology, American Journal of Gastroenterology, Gut
more...
|
250 Available Pages
|
|
